In a patient with restless‑legs syndrome who is already taking gabapentin 1200 mg daily, would adding lorazepam (Ativan) be beneficial?

Do Not Add Lorazepam to Gabapentin for Restless Legs Syndrome

The American Academy of Sleep Medicine (AASM) 2025 guidelines explicitly recommend against using benzodiazepines, including clonazepam (and by extension lorazepam), for RLS treatment 1. Adding lorazepam would not address the underlying RLS pathophysiology and carries significant risks without proven benefit for RLS symptoms.

Why Lorazepam Should Not Be Added

Guideline-Based Recommendation

The most recent AASM clinical practice guideline (2025) specifically states: "In adults with RLS, the AASM suggests against the use of clonazepam (conditional recommendation, very low certainty of evidence)" 1. While this specifically mentions clonazepam, the recommendation extends to the benzodiazepine class, including lorazepam. No benzodiazepine has demonstrated efficacy for the core symptoms of RLS in controlled trials 2.

Evidence Gap

A comprehensive Cochrane review found zero studies meeting inclusion criteria for benzodiazepines in RLS treatment 2. The review concluded: "The effectiveness of benzodiazepines for RLS treatment is currently unknown." This represents a complete absence of quality evidence supporting their use.

Safety Concerns with Lorazepam

The FDA labeling for lorazepam (Ativan) highlights multiple risks particularly relevant to RLS patients 3:

• Respiratory depression - especially concerning if used chronically
• Prolonged sedation - effects lasting 24-48 hours, worse in patients over 50
• Dependency and withdrawal - significant risk with chronic use
• Cognitive impairment - additive sedation that may worsen quality of life

What to Do Instead

Optimize Current Gabapentin Therapy

The patient is already on gabapentin 1200 mg daily, which the AASM strongly recommends for RLS 1. Before adding anything:

1. Verify dosing schedule: Gabapentin should be taken 1-2 hours before symptom onset (typically evening)
2. Consider dose optimization: Effective RLS doses range up to 3600 mg/day in divided doses 4, 5
3. Check absorption: Taking with food enhances gabapentin absorption

Evidence-Based Alternatives if Gabapentin Alone is Insufficient

First-tier options (Strong AASM recommendations):

• Pregabalin: Strong recommendation, may be more effective than gabapentin at equivalent doses 1
• IV ferric carboxymaltose: Strong recommendation if ferritin <75 ng/mL or transferrin saturation <20% 1

Second-tier options (Conditional AASM recommendations):

• Oral ferrous sulfate: If iron parameters are suboptimal 1
• Dipyridamole: Conditional recommendation, low certainty evidence 1
• Extended-release oxycodone or other opioids: Conditional recommendation for refractory cases 1

Critical Evaluation Steps Before Changing Therapy

1. Check iron studies: Ferritin and transferrin saturation - iron deficiency is a reversible cause
2. Review medication list: Many drugs worsen RLS (antidepressants, antihistamines, antipsychotics)
3. Assess for secondary causes: Renal disease, pregnancy, neuropathy
4. Evaluate symptom timing: Ensure gabapentin is dosed appropriately for symptom pattern

Common Pitfalls to Avoid

Do not use benzodiazepines as a "sleep aid" in RLS patients. While RLS disrupts sleep, benzodiazepines do not treat the underlying sensorimotor symptoms and may mask inadequate RLS treatment while adding dependency risk 6, 7.

Do not assume sedation equals RLS treatment. Lorazepam may help sleep initiation through sedation, but RLS symptoms will persist and may worsen quality of life through daytime sedation and cognitive effects.

Do not combine CNS depressants without clear indication. Gabapentin already carries sedation risk; adding lorazepam significantly increases risk of respiratory depression, falls, and cognitive impairment, particularly in older adults 3.

Clinical Reasoning

The 2025 AASM guidelines represent a significant shift, moving dopamine agonists to "conditional against" due to augmentation and impulse control risks, while elevating gabapentinoids to first-line therapy 8. This patient is already on appropriate first-line therapy. The logical next steps involve optimizing gabapentin dosing, addressing iron status, or switching to pregabalin - not adding a medication with no proven RLS efficacy and substantial harm potential.

If sleep remains problematic despite adequate RLS control, address sleep hygiene and consider sleep-specific interventions rather than benzodiazepines.